Jan-mou Lee

TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Higher yields of Vγ9Vδ2 T cells from peripheral blood than umbilical cord blood via interleukin-12 and interleukin-18.

Higher yields of Vγ9Vδ2 T cells from peripheral blood than umbilical cord blood via interleukin-12 and interleukin-18.

Journal: Cytotherapy
Published: March 16, 2026

Establishment of a Flow Cytometry Protocol for Binarily Detecting Circulating Tumor Cells with EGFR Mutation.

Establishment of a Flow Cytometry Protocol for Binarily Detecting Circulating Tumor Cells with EGFR Mutation.

Journal: Diseases (Basel, Switzerland)
Published: August 19, 2025

Detecting HER2-positive circulating tumor cells in gastric cancer using a flow cytometry-based approach.

Detecting HER2-positive circulating tumor cells in gastric cancer using a flow cytometry-based approach.

Journal: Frontiers in medicine
Published: July 25, 2025

Characterizing immune cell profiles of patients with rheumatoid arthritis in Taiwan using artificial intelligence-based cytometric approaches.

Characterizing immune cell profiles of patients with rheumatoid arthritis in Taiwan using artificial intelligence-based cytometric approaches.

Journal: Journal of leukocyte biology
Published: June 09, 2025

Molecular profiling of circulating tumor cells guides effective EGFR inhibitor treatment in advanced hepatocellular carcinoma: a case report.

Molecular profiling of circulating tumor cells guides effective EGFR inhibitor treatment in advanced hepatocellular carcinoma: a case report.

Journal: Frontiers in oncology
Published: April 09, 2025

Characterizing immune profiles in hepatocellular carcinoma patients benefiting from pembrolizumab and lenvatinib using machine learning.

Characterizing immune profiles in hepatocellular carcinoma patients benefiting from pembrolizumab and lenvatinib using machine learning.

Journal: BMC cancer
Published: March 31, 2025

Establishment of a protocol for rapidly expanding Epstein-Barr-virus-specific cytotoxic T cells with enhanced cytotoxicity.

Establishment of a protocol for rapidly expanding Epstein-Barr-virus-specific cytotoxic T cells with enhanced cytotoxicity.

Journal: BMC cancer
Published: April 15, 2024

Characterization of unique pattern of immune cell profile in patients with nasopharyngeal carcinoma through flow cytometry and machine learning.

Characterization of unique pattern of immune cell profile in patients with nasopharyngeal carcinoma through flow cytometry and machine learning.

Journal: Journal of cellular and molecular medicine
Published: January 14, 2024

Characterization of tumoricidal activities mediated by a novel immune cell regimen composing interferon-producing killer dendritic cells and tumor-specific cytotoxic T lymphocytes.

Characterization of tumoricidal activities mediated by a novel immune cell regimen composing interferon-producing killer dendritic cells and tumor-specific cytotoxic T lymphocytes.

Journal: BMC cancer
Published: December 12, 2023

Enhanced tumor control activities of anti-mPD-L1 antibody and antigen-presenting cell-like natural killer cell in an allograft model.

Enhanced tumor control activities of anti-mPD-L1 antibody and antigen-presenting cell-like natural killer cell in an allograft model.

Journal: BMC cancer
Published: September 15, 2023

Artificial intelligence-based immunoprofiling serves as a potentially predictive biomarker of nivolumab treatment for advanced hepatocellular carcinoma.

Artificial intelligence-based immunoprofiling serves as a potentially predictive biomarker of nivolumab treatment for advanced hepatocellular carcinoma.

Journal: Frontiers in medicine
Published: August 01, 2022

Novel immunoprofiling method for diagnosing SLE and evaluating therapeutic response.

Novel immunoprofiling method for diagnosing SLE and evaluating therapeutic response.

Journal: Lupus science & medicine
Published: March 07, 2022
Showing 1-12 of 13

Last Updated: 09/26/2026